{"id":33424,"date":"2019-09-30T15:25:11","date_gmt":"2019-09-30T13:25:11","guid":{"rendered":"https:\/\/www.aiom.it\/?p=33424"},"modified":"2019-10-07T15:27:31","modified_gmt":"2019-10-07T13:27:31","slug":"efficacy-and-safety-results-from-geico-1205-a-randomized-phase-ii-trial-of-neoadjuvant-chemotherapy-with-or-without-bevacizumab-for-advanced-epithelial-ovarian-cancer","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/efficacy-and-safety-results-from-geico-1205-a-randomized-phase-ii-trial-of-neoadjuvant-chemotherapy-with-or-without-bevacizumab-for-advanced-epithelial-ovarian-cancer\/","title":{"rendered":"Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer"},"content":{"rendered":"<p><em>Garcia Garcia Y, de Juan Ferr\u00e9 A, Mendiola C, Barretina-Ginesta MP, Gaba Garcia L, Santaballa Bertr\u00e1n A, Bover Barcelo I, Gil-Martin M, Manzano A, Rubio P\u00e9rez MJ, Romeo Marin M, Arqueros N\u00fa\u00f1ez C, Garc\u00eda-Mart\u00ednez E, Gonzalez Martin A. <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-33415\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2019\/09\/IJGC-222x300.jpg\" alt=\"\" width=\"222\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2019\/09\/IJGC-222x300.jpg 222w, https:\/\/www.aiom.it\/wp-content\/uploads\/2019\/09\/IJGC.jpg 589w\" sizes=\"auto, (max-width: 222px) 100vw, 222px\" \/><\/em><\/p>\n<p><em>International Journal of Gynecological Cancer, 2019 Jul.<\/em><\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31263024\">Link all&#8217;abstract<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Garcia Garcia Y, de Juan Ferr\u00e9 A, Mendiola C, Barretina-Ginesta MP, Gaba Garcia L, Santaballa Bertr\u00e1n A, Bover Barcelo I, Gil-Martin M, Manzano A, Rubio P\u00e9rez MJ, Romeo Marin M, Arqueros N\u00fa\u00f1ez C, Garc\u00eda-Mart\u00ednez E, Gonzalez Martin A. International Journal of Gynecological Cancer, 2019 Jul. Link all&#8217;abstract<\/p>\n","protected":false},"author":11,"featured_media":33423,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[256],"class_list":["post-33424","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en","tag-carcinoma-ovarico-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/33424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=33424"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/33424\/revisions"}],"predecessor-version":[{"id":33426,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/33424\/revisions\/33426"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/33423"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=33424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=33424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=33424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}